Published in Morphol Embryol (Bucur) on March 24, 1983
Latent cytomegalovirus infection in blood donors. Br Med J (1969) 2.61
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2007) 1.62
Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis. J Rheumatol (1997) 1.61
Enumeration and isolation of human T and B lymphocytes by rosette formation with antibody-coated erythrocytes. Clin Exp Immunol (1975) 1.32
Cytomegalovirus infection associated with pregnancy. Lancet (1967) 1.26
Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum (1996) 1.23
Biological and physicochemical properties of ground squirrel cytomegalovirus. Am J Vet Res (1970) 1.18
Identification of five human lymphocyte subpopulations by their differential binding of various strains of bacteria. Cell Immunol (1977) 1.16
Lipoma of submandibular space with osseous metaplasia. Report of a case. Oral Surg Oral Med Oral Pathol (1973) 1.15
Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes. J Immunol (1985) 1.14
The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer (1994) 1.05
The response to mitogens and allogeneic cells of human lymphocyte subpopulations separated by their differential binding to monolyaers of bacteria. J Immunol (1978) 1.03
The identification of six mouse lymphocyte subpopulations by their natural binding of bacteria. J Immunol (1978) 1.02
The use of the natural binding of bacteria for the identification of human T- and B-lymphocyte subpopulations in blood smears. Clin Immunol Immunopathol (1979) 1.01
Recovery of cytomegalovirus from the submaxillary glands of ground squirrels. Arch Gesamte Virusforsch (1967) 0.98
The relationship between the percentage of circulating B cells, corticosteroid levels, and other immunologic parameters in thermally injured patients. J Trauma (1989) 0.98
Different optimal temperatures for the biologic activity of rabbit and human lymphocytes in vitro. Arch Roum Pathol Exp Microbiol (1973) 0.98
Cytomegalovirus infection and sudden death in infants. J Pediatr (1974) 0.97
Enumeration and isolation of rabbit T and B lymphocytes by using antibody-coated erythrocytes. J Immunol (1976) 0.97
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. Arthritis Rheum (2013) 0.96
Binding of bacteria to lymphocyte subpopulations. Adv Immunol (1982) 0.96
High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol (1998) 0.96
Cytophagia in cell cultures infected with cytomegalovirus. J Infect Dis (1972) 0.96
Rabbit lymphocyte subpopulations. I. Separation of Ig+ and Ig- cells and their interaction in cultures stimulated by mitogens. Cell Immunol (1976) 0.96
Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis (2010) 0.94
Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 0.93
The mechanism of natural binding of bacteria to human lymphocyte subpopulations. J Clin Lab Immunol (1983) 0.93
Isolation of human spontaneous killer lymphocytes by bacterial adherence. Clin Exp Immunol (1980) 0.93
Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol (2000) 0.92
Maintenance of lymphocyte surface Ig by mitogen stimulation in vitro. J Immunol (1975) 0.91
Characterization and role in autoimmune diseases of the polyclonal B-cell activator produced by T-cells-the helper factor. Immunol Rev (1981) 0.90
Duration of cytomegaloviruria in nursery children. Pathol Microbiol (Basel) (1966) 0.89
An alpha2-macroglobulin associated factor produced by T lymphocytes which provides polyclonal stimulation of B lymphocytes to maintain the turnover of their surface Ig. Immunology (1981) 0.89
Leukaemia and cytomegalovirus infection. Pathol Microbiol (Basel) (1969) 0.88
Polyclonal B cell activator associated with alpha-2-macroglobulin in the serum of patients with rheumatoid arthritis. Int Arch Allergy Appl Immunol (1981) 0.87
Circannual variations in the B cell/T cell ratio in normal human peripheral blood. J Allergy Clin Immunol (1981) 0.86
Genetic control of resistance to mouse cytomegalovirus infection. Arch Gesamte Virusforsch (1974) 0.86
Identification and separation by bacterial adherence of human lymphocytes that suppress natural cytotoxicity. J Immunol (1981) 0.86
L-Asparaginase from the BCG strain of Mycobacterium bovis. I. Purification and in vitro immunosuppressive properties. Can J Biochem (1972) 0.86
Cytomegalovirus type cytopathic changes in spontaneously degenerating human embryonic cell cultures. Nature (1967) 0.86
Relationship between bacterial binding to lymphocytes and clinical features in chronic lymphocytic leukemia. Cancer (1979) 0.85
Immunobiological function of normal rabbit synovial cells. Cell Immunol (1985) 0.84
T-independent but not T-dependent antigens maintain surface Ig of lymphocytes. Cell Immunol (1979) 0.84
Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis. Arthritis Rheum (1984) 0.84
Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B. J Immunol Methods (1984) 0.84
The turnover of surface immunoglobulins of small lymphocytes and blastic cells. Cell Immunol (1980) 0.83
Polyclonal B-cell activator with esterolytic activity and polyclonal gammopathy induced by allogeneic cells in rabbits. Immunology (1982) 0.83
Enumeration of human B lymphocytes in stained blood smears by their binding of bacteria. Clin Immunol Immunopathol (1978) 0.83
The use of mutants of Escherichia coli for the identification of human lymphocyte subpopulations in blood smears. J Immunol (1983) 0.83
[Viral particles in the kidney in Balkan endemic nephropathy]. Sem Hop (1970) 0.83
Functional characterization of mouse lymphocyte subpopulations identified by their natural binding of bacteria. I. Identification of the Ig-secreting cell subpopulation. J Immunol (1979) 0.83
Inactivation of human interleukin-2 (IL-2) by alpha 2-macroglobulin-trypsin complexes. Immunology (1986) 0.83
Human lymphocyte subpopulations identified by bacterial adherence are functionally different. Cell Immunol (1979) 0.83
The use of Salmonella schottmulleri for mapping and separation of human lymphocyte subpopulations. Immunobiology (1981) 0.83
Cell differentiation and pseudodifferentiation in in vitro cultures of spleen. Exp Cell Res (1969) 0.82
Bacterial adherence to eucaryotic cells: isolation of lymphocyte-binding mutants. Infect Immun (1980) 0.82
Identification of basophils as the cells bearing both allelic immunoglobulin allotypes among white blood cells from the peripheral blood of heterozygous rabbits. J Immunol (1980) 0.82
Differences in clinical sensitivity of ELISA tests for autoantibodies with human and bovine extractable nuclear antigens. Lupus (2000) 0.82
Factors affecting the differential counting of human lymphocyte subpopulations in blood smears. Clin Exp Immunol (1980) 0.82
Identification of a cytomegalovirus recovered from field mice. Pathol Microbiol (Basel) (1972) 0.82
Electrophysiological changes in optic neuropathy of streptozotocin induced diabetic rats. J Med Life (2013) 0.81
A simple radioimmunoassay for the enumeration of rosette-forming cells. J Immunol Methods (1975) 0.81
Increase in proliferation and cytotoxic cell development in human mixed lymphocyte cultures in the presence of very low concentrations of LPS: role of IL-1 and prostaglandin E2. Clin Immunol Immunopathol (1986) 0.81
Rabbit lymphocyte subpopulations. II. Separation and characterization of two Ig+ cell subpopulations. Cell Immunol (1976) 0.81
Blast transformation of B cells induced by an alpha-macroglobulin-associated lymphokine produced in crowded lymphoid cell cultures. J Immunol (1983) 0.81
Allelic allotype inclusion and exclusion among rabbit Ig-bearing lymphocytes of peripheral blood and lymphoid organs. Cell Immunol (1977) 0.80
Induction with nitrous acid of dextran sulfate resistance in type 1 poliovirus. Virology (1966) 0.80
The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritis. Int J Immunopharmacol (1982) 0.79
[Anatomo-clinical aspects of Balkan endemic nephropathy]. Sem Hop (1966) 0.79
Proliferative activity and antibody synthesis in cultures of lymphoid cells grown in a serum free medium. Arch Roum Pathol Exp Microbiol (1972) 0.79
Dependence of lymphocyte surface Ig on continuous polyclonal activation. Immunology (1979) 0.79
Enumeration and identification of human leukemic lymphocytes by their natural binding of bacteria. Cancer Res (1977) 0.79
Surface immunoglobulin in immunoproliferative diseases. Ann Clin Lab Sci (1978) 0.78
Incidence of cytomegalic infection in man. Pathol Microbiol (Basel) (1967) 0.78
The influence of smallpox revaccination upon the foetus. Virologie (1975) 0.78
Porcine coronavirus antibodies in endemic (Balkan) nephropathy. Lancet (1978) 0.78
Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB). J Rheumatol (1990) 0.78
Degeneration of cytomegalovirus-infected cells in lymph nodes of naturally infected guinea-pigs. Rev Roum Morphol Physiol (1974) 0.78
Letter: Viruses in endemic (Balkan) nephropathy. Lancet (1976) 0.78
The role of intercellular contacts in the activation of B lymphocytes by anti-immunoglobulin antibodies. J Immunol (1985) 0.78
De novo production of IgG antinuclear antibodies in a neonate. J Rheumatol (2001) 0.77
Lack of recovery from radiation induced chromosome damage in G0 human lymphocytes. Exp Cell Res (1972) 0.77
Simultaneous identification of T and B cells in blood smears using antibody coated bacteria. Cell Immunol (1976) 0.77
IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis. Lupus (2011) 0.77
Enumeration of lymphocytes and their subpopulations identified by bacterial adherence in blood smears of patients with breast tumors. J Surg Oncol (1981) 0.77
Specific binding of IL-8 to rabbit alpha-macroglobulin modulates IL-8 function in the lung. Inflamm Res (2000) 0.77
A low molecular weight proteinase inhibitor produced by T lymphocytes. Immunology (1986) 0.76
Immunoglobulin content and antibody activity in an artificial body cavity. Immunol Commun (1976) 0.76
Effect of circulating immune complexes on the binding of rheumatoid factor to histones. Ann Rheum Dis (2000) 0.76
Chromosome abnormalities in chronic active hepatitis. J Clin Pathol (1972) 0.76
Factors produced in cultures of human lymphocytes stimulated by phytohemagglutinin (PHA). I. Skin-reactive factor (SRF): characterization and immunochemical study. Int Arch Allergy Appl Immunol (1972) 0.76
A hypothesis on the role of immune RNA in antibody variability. J Theor Biol (1973) 0.76
Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun (2002) 0.76
[Intrauterine infections due to cytomegalic virus]. Gynecol Obstet (Paris) (1970) 0.76
Allogeneic lymphocyte stimulation in rabbits: induction of a low MW inhibitor for trypsin and for a concurrently induced alpha-macroglobulin-proteinase complex. Immunology (1985) 0.76
Binding of bacteria from the genus Brucella to human B lymphocytes. Infect Immun (1981) 0.76